Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03225859 |
Other study ID # |
D2525-P |
Secondary ID |
1I21RX002525-01A |
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
November 5, 2018 |
Est. completion date |
February 28, 2020 |
Study information
Verified date |
February 2021 |
Source |
VA Office of Research and Development |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Veterans who complete trauma-focused therapies (TFTs) report improvements in posttraumatic
stress disorder symptoms, quality of life, and social and role functioning. However, many
also report uncertainty regarding their ability to maintain and build upon progress made
during TFTs following the end of treatment. Veterans who recently completed a course of TFT
believe the likelihood of their ongoing success would be bolstered by mental health services
that support additional practice and reinforcement of skills learned in TFT. Currently no
evidence-based approach for post-TFT care exists; however, Veterans' reported treatment needs
are well-suited to a therapist-assisted self-management approach. The objective of this
project is to complete Stage 1 (intervention refinement and piloting) of the Stage Model of
Treatment Development for a post-TFT therapist-assisted self-management program designed to
help Veterans maintain or build upon gains made in TFT, increase self-efficacy for managing
their PTSD symptoms, and enhance community engagement. The aims of the project are to: 1)
Refine a self-management treatment protocol through eliciting feedback from experienced TFT
providers on a draft of the self-management program, 2) Conduct a pilot open trial to assess
the acceptability and feasibility of the self-management program, and 3) Explore the effects
of the program on Veterans' confidence in managing their PTSD and Veterans' functioning,
quality of life, community engagement, and mental health symptoms.
Description:
Impact: Findings from this project will improve the mental health and well-being of Veterans
with posttraumatic stress disorder (PTSD) by refining and evaluating the first post-trauma
focused therapy (TFT) intervention designed to help Veterans increase self-efficacy for
managing their PTSD symptoms, maintain or build upon gains made in TFT, and increase
community engagement. The current VA / Department of Defense PTSD clinical practice
guidelines recommend decreasing the frequency and intensity of care (e.g. stepping-down)
following successful TFT completion; this project is the initial step in developing the first
evidence-based intervention for this important process. The project will advance RR&D's
missions of evaluating interventions designed to maximize psychological recovery and
prioritizing functional outcomes and societal engagement. Finally, the project will advance
the scientific literature by being the first examination of a self-management intervention
designed to be used to step down from an intensive course of therapy for PTSD.
Background: TFTs reduce the suffering associated with PTSD; a majority of Veterans who
complete prolonged exposure or cognitive processing therapy report improvements in PTSD
symptomology, quality of life, and functioning. Despite their effectiveness, emerging data
suggest that Veterans who complete TFTs continue to perceive a need for mental health
treatment; the investigators' pilot data demonstrated that the primary post-TFT mental health
treatment need among completers who experienced at least a partial improvement in PTSD
symptoms is support for additional practice and reinforcement of skills learned in TFT.
Veterans expressed low self-efficacy for maintaining or building upon their existing gains
and believed continued contact with their TFT therapist would increase their likelihood of
success. These treatment needs are particularly well-suited to a therapist-assisted
self-management approach. Self-management protocols teach patients to be responsible for the
day-to-day management of their symptoms, thereby emphasizing patients' roles in wellness. The
existing literature on self-management interventions for PTSD has demonstrated that such
approaches are acceptable, safe, and effective; however, they have exclusively been used as
stand-alone treatments or as the first step up in a stepped-care model. Therefore, the
investigators are proposing the first examination of a self-management intervention designed
to be used to step down from an intensive course of TFT for PTSD.
Objectives: The objective of this study is to complete stages 1A and 1B of the Stage Model of
Treatment Development for the self-management program for Veterans who have recently
completed a course of TFT for PTSD. Specifically, the investigators will: (1) Refine a
self-management treatment protocol through eliciting feedback from experienced TFT providers,
(2) Conduct a pilot open trial to assess the (a) acceptability of the self-management program
components, structure, and materials and (b) feasibility of the self-management program
(retention and intervention fidelity) and study approach (screening, recruitment, assessment
process), and (3) Explore the effects of the program on Veterans' confidence in managing
their PTSD (self-efficacy), functioning, quality of life, community engagement, and mental
health symptoms.
Methods: To achieve Aim 1, the investigators will conduct semi-structured individual
interviews with a sample of TFT providers (n = 10-12), during which participants will be
asked to provide feedback on the planned components and structure of the self-management
program. To achieve Aims 2 and 3, the investigators will enroll twelve Veterans in a
non-randomized, open-trial pilot test of the intervention at the Minneapolis VA Healthcare
Systems (VAHCS). Enrolled Veterans will complete survey batteries immediately post-TFT, and
survey batteries and qualitative interviews two weeks after the final self-management program
therapist contact. Findings from this project will strongly position us to apply for Merit
funding to conduct a randomized clinical trial (Stage 2 of the Stage Model of Treatment
Development) of this innovative self-management program.